[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1169594A1 - 鹵代脂肪族羧酸及其寡聚物和/或聚合物以及其在失活外部和內部腫瘤中的應用 - Google Patents

鹵代脂肪族羧酸及其寡聚物和/或聚合物以及其在失活外部和內部腫瘤中的應用

Info

Publication number
HK1169594A1
HK1169594A1 HK12110254.6A HK12110254A HK1169594A1 HK 1169594 A1 HK1169594 A1 HK 1169594A1 HK 12110254 A HK12110254 A HK 12110254A HK 1169594 A1 HK1169594 A1 HK 1169594A1
Authority
HK
Hong Kong
Prior art keywords
devitalizing
oligomers
polymers
external
carboxylic acids
Prior art date
Application number
HK12110254.6A
Other languages
English (en)
Inventor
Shalva Mardi
Rosa Mardi
Gymsher Mardi
Laura Mardi
Shimon Slavin
Original Assignee
Cimas Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cimas Ltd filed Critical Cimas Ltd
Publication of HK1169594A1 publication Critical patent/HK1169594A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/305Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • C07C59/315Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/08Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62Halogen-containing esters
    • C07C69/63Halogen-containing esters of saturated acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/708Ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK12110254.6A 2009-06-09 2012-10-17 鹵代脂肪族羧酸及其寡聚物和/或聚合物以及其在失活外部和內部腫瘤中的應用 HK1169594A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18522609P 2009-06-09 2009-06-09
PCT/IL2010/000455 WO2010143188A2 (en) 2009-06-09 2010-06-09 Halogenated aliphatic carboxylic acids, oligomers and/or polymers thereof and their use in devitalizing external and internal neoplasms

Publications (1)

Publication Number Publication Date
HK1169594A1 true HK1169594A1 (zh) 2013-02-01

Family

ID=42578223

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12110254.6A HK1169594A1 (zh) 2009-06-09 2012-10-17 鹵代脂肪族羧酸及其寡聚物和/或聚合物以及其在失活外部和內部腫瘤中的應用

Country Status (14)

Country Link
US (2) US9283199B2 (zh)
EP (1) EP2440198B1 (zh)
JP (1) JP2012529497A (zh)
KR (1) KR20120099360A (zh)
CN (1) CN102695503A (zh)
AR (1) AR077040A1 (zh)
AU (1) AU2010258231A1 (zh)
BR (1) BRPI1009037A2 (zh)
CA (1) CA2763862C (zh)
EA (1) EA201270016A1 (zh)
HK (1) HK1169594A1 (zh)
MX (1) MX2011013223A (zh)
SG (3) SG190611A1 (zh)
WO (1) WO2010143188A2 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102695503A (zh) 2009-06-09 2012-09-26 马迪医学有限公司 卤代脂族羧酸、其寡聚物和/或聚合物和它们使外部和内部瘤失活的用途
RU2482856C2 (ru) 2011-08-05 2013-05-27 Общество С Ограниченной Ответственностью "Оксигон" Комплексное соединение 2-хлорпропионата цинка и 2-хлорпропионовой кислоты, фармацевтическая композиция для лечения заболеваний кожи, способ ее получения и способ лечения поражений кожи, ногтей и видимых слизистых
EP2753175B1 (en) * 2011-09-07 2019-02-06 The Scripps Research Institute Chiral compounds of varying conformational rigidity and methods of synthesis

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US275258A (en) 1883-04-03 Edward palliser
US2734075A (en) * 1953-04-06 1956-02-07 a-dichloropropionic acid esters of the
LU68060A1 (zh) * 1973-07-20 1975-04-11
US4624851A (en) * 1983-04-22 1986-11-25 Elena Avram Treatment of symptoms of neoplastic diseases
US4824955A (en) * 1985-11-15 1989-04-25 Nippon Kayaku Kabushiki Kaisha Selenium oxy chloride-pyridine or bipyridine complexes
WO1995011699A1 (en) 1993-10-29 1995-05-04 The Trustees Of Boston University Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents
DE4407484A1 (de) * 1993-12-03 1995-06-08 Werner Prof Dr Kreutz Medikament zur Krebs-Therapie
US5716959A (en) * 1996-02-13 1998-02-10 T. Ronald Theodore Method of treating disease with piperazine zwitterion compounds
JPH09227388A (ja) 1996-02-15 1997-09-02 Naganushi Tetsuaki 大腸癌、食道癌及び乳癌より選ばれた癌に用いる抗悪性腫瘍剤
JPH10130153A (ja) 1996-10-28 1998-05-19 Shiyumeidou:Kk 大腸癌、食道癌及び乳癌より選ばれた癌に用いる 抗悪性腫瘍剤
US6414037B1 (en) 1998-01-09 2002-07-02 Pharmascience Pharmaceutical formulations of resveratrol and methods of use thereof
JP2000298346A (ja) * 1999-04-14 2000-10-24 Toray Ind Inc ポジ型感放射線性組成物およびこれを用いたレジストパターンの製造法
EP1293498A1 (en) * 2001-08-30 2003-03-19 Mardi, Shalva Selenium complex with haloethanoic acid or its anhydride, and use thereof in the topical treatment of neoplasms
US20030143165A1 (en) 2002-01-25 2003-07-31 Allan Evans NSAID-containing topical formulations that demonstrate chemopreventive activity
CA2489592A1 (en) * 2002-06-12 2003-12-24 Amato Pharmaceutical Products, Ltd. Inhibitor of anticancer drug side effect
GB0220045D0 (en) * 2002-08-29 2002-10-09 Cxr Biosciences Ltd Sc 211745 Methods
FR2845599B1 (fr) 2002-10-11 2005-01-07 Lmd Medicament comprenant une thiouree pour son utilisation en tant que depigmentant
EP1491188A1 (en) 2003-06-25 2004-12-29 G2M Cancer Drugs AG Topical use of valproic acid for the prevention or treatment of skin disorders
RU2261243C1 (ru) 2004-01-19 2005-09-27 Шалва Марди Соли цинка и галоидкарбоновых кислот алифатического ряда для лечения новообразований кожи и видимых слизистых покровов
US20070149618A1 (en) 2004-02-17 2007-06-28 Action Medicines, S.L. Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis
WO2006024489A2 (en) * 2004-08-30 2006-03-09 Interstitial Therapeutics Methods and compositions for the treatment of cell proliferation
US20090209618A1 (en) * 2004-10-08 2009-08-20 Dang Chi V Pyruvate dehydrogenase kinases as therapeutic targets for cancer and ischemic diseases
WO2006108276A1 (en) * 2005-04-11 2006-10-19 The Governors Of The University Of Alberta A method of treating cancer using dichloroacetate
EP1746082A1 (en) * 2005-07-19 2007-01-24 Anatoly Fyodorovich Tsyb Salts of zinc and aliphatic haloid carboxylic acids for therapy of skin neoplasms and visible mucous coats
AU2006321915B2 (en) * 2005-12-06 2012-04-26 Covidien Lp Bioabsorbable surgical composition
US20080187511A1 (en) 2006-10-25 2008-08-07 University Of Pittsburgh-Of The Commonwealth Ointment for cancer treatment
RU2366648C2 (ru) * 2007-08-28 2009-09-10 Медилик Пте.Лтд. Продукт взаимодействия двуокиси селена с алифатическими галоидкарбоновыми кислотами, способ получения продукта, раствор продукта и способ лечения доброкачественных, вирусных, предзлокачественных и злокачественных неметастазирующих поражений кожи, диспластических поражений видимых слизистых оболочек и иных поражений кожи
RU2375054C2 (ru) * 2007-10-18 2009-12-10 Медилик Пте.Лтд. Препарат для лечения поражений кожи, способ получения препарата (варианты) и способ лечения поражений кожи
CN102695503A (zh) 2009-06-09 2012-09-26 马迪医学有限公司 卤代脂族羧酸、其寡聚物和/或聚合物和它们使外部和内部瘤失活的用途
US10310824B2 (en) 2011-09-07 2019-06-04 Imagine Communications Corp. Distributed ledger platform for computing applications
GB201216800D0 (en) 2012-09-20 2012-11-07 Immodulon Therapeutics Ltd Novel use
WO2017112786A1 (en) 2015-12-21 2017-06-29 Google Inc. Automatic suggestions for message exchange threads
TWI745100B (zh) 2020-09-25 2021-11-01 壟銓科技股份有限公司 背包式防彈衣
US11924354B2 (en) 2021-03-19 2024-03-05 Jpmorgan Chase Bank, N.A. Data center recovery pod systems and methods

Also Published As

Publication number Publication date
WO2010143188A2 (en) 2010-12-16
SG176636A1 (en) 2012-01-30
CN102695503A (zh) 2012-09-26
KR20120099360A (ko) 2012-09-10
US20110052641A1 (en) 2011-03-03
SG190612A1 (en) 2013-06-28
EP2440198A2 (en) 2012-04-18
EA201270016A1 (ru) 2012-06-29
JP2012529497A (ja) 2012-11-22
US20160067198A1 (en) 2016-03-10
CA2763862C (en) 2017-04-25
SG190611A1 (en) 2013-06-28
MX2011013223A (es) 2012-06-19
EP2440198B1 (en) 2016-01-06
BRPI1009037A2 (pt) 2017-06-06
WO2010143188A3 (en) 2011-05-26
AR077040A1 (es) 2011-07-27
AU2010258231A1 (en) 2011-12-22
US9283199B2 (en) 2016-03-15
CA2763862A1 (en) 2010-12-16

Similar Documents

Publication Publication Date Title
EP2274043A4 (en) BIODEGRADABLE METAL-CHELATING POLYMERS AND VACCINES
PL2470517T3 (pl) Estry kwasu 2,5-furanodikarboksylowego z izometrycznymi dekanolami i ich zastosowanie
EP2501698A4 (en) FLUORINATED MONOMERS, OLIGOMERS AND POLYMERS FOR USE IN ORGANIC ELECTRONIC DEVICES
HK1199031A1 (zh) 取代的 -乙酰胺基- -芳基- -三唑酮和它的用途
HK1192879A1 (zh) 取代的 -苄基環烷基羧酸及其用途
HK1177195A1 (zh) 取代的 -苯基丙酸和其應用
EP2259241A4 (en) ALARM UNIT AND ALARM SYSTEM
HK1155168A1 (zh) 氧代雜環取代的羧酸衍生物和它的用途
EP2468010A4 (en) PRE-REGISTRATION / PRE-AUTHENTICATION IN WIRELESS NETWORKS
EP2568875A4 (en) WIRELESS MOLECULAR SENSOR SYSTEM AND METHOD THEREOF
EP2422194A4 (en) VESICULAR SYSTEM AND USES THEREOF
GB0902052D0 (en) Polymers,composition and use
EP2395040A4 (en) FLUORINATED DICARBOXYLIC ACID DERIVATIVE AND POLYMER OBTAINED THEREFROM
EP2464679A4 (en) IMPROVED NYLON RESINS AND METHOD THEREFOR
HK1153566A1 (en) Anti-theft rfid system and method thereof
EP2507256A4 (en) IMP-3 OLIGOPEPTIDES AND VACCINES THEREWITH
PT2379641T (pt) Produtos de ácido poliláctico e sua utilização
EP2427349A4 (en) IMPACT WARNING SYSTEM AND METHOD
EP2480588A4 (en) RECONSTITUTABLE INVERTED HEAT GELING POLYMERS
HK1169594A1 (zh) 鹵代脂肪族羧酸及其寡聚物和/或聚合物以及其在失活外部和內部腫瘤中的應用
PL2430057T3 (pl) Kopolimery wrażliwe na temperaturę i ich zastosowanie
IL216870A0 (en) Halogenated aliphatic carboxylic acids, oligomers and/or polymers thereof and their use in devitalizing external and internal neoplasms
EP2502916A4 (en) ORGANIC DICARBOXYLIC ACIDS, THEIR SALTS AND PROCESS FOR THEIR PREPARATION
PL2491021T3 (pl) Nowe acylopiperazynony i ich zastosowanie jako środki farmaceutyczne
EP2469334A4 (en) STROBOSCOPE DEVICE AND IMAGING DEVICE THEREFOR

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200606